G. Naveena*, B. Vasanthi, Dr. S. B. Uday Shankar, Nallani Venkata RamaRao


Modern day drug therapy for the control of seizures has made great studies in the recent past. The adverse reactions, although rare, still remain a major threat to the patient welfare. Stevens-Johnson syndrome (SJS) is one such fatal drug reactions. “A new eruptive fever with stomatitis and opthalmia” was described as a severe variant of erythema multiforme & was termed by Steven and Johnson in 1922. By the 1940’s it was commonly called as “Steven Johnson’s syndrome (SJS)”. The concept of the spectrum of erythema multiforme has been widely accepted since that time.[1] The overall incidence of Stevens Johnson Syndrome is seen 1 to 6 per million per Year.[2] When more than 30% Body Surface Area sloughing is present, the mortality rate rises to 25%.[3] The incubation period is 4 days to 4 weeks. SJS is characterized by sudden onset, marked constitutional symptoms of high fever, malaise, myalgia, arthralgia and extensive erythema multiforme like lesions and subsequent skin blisters and erosions. Early diagnosis and treatment is associated with favourable prognosis and less incidence of complications.[4] Phenytoin is the most commonly prescribed antiepileptic drug in adults.[5] phenytoin (PHT) was the most common cause of antiepileptic drugs (AEDs)-induced cutaneous adverse reactions.[6]

Keywords: .

[Full Text Article]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation


    FEBRUARY 2023 Issue has been successfully launched on 1 FEBRUARY 2023.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction